213 related articles for article (PubMed ID: 26359512)
1. Effect of High-Dose Statin Therapy on Drug-Eluting Stent Strut Coverage.
Kim JS; Kim JH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2460-7. PubMed ID: 26359512
[TBL] [Abstract][Full Text] [Related]
2. Optical coherence tomography analysis of strut coverage in biolimus- and sirolimus-eluting stents: 3-month and 12-month serial follow-up.
Kim BK; Hong MK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y
Int J Cardiol; 2013 Oct; 168(5):4617-23. PubMed ID: 23932862
[TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of acute stent malapposition between platinum-chromium versus cobalt-chromium everolimus-eluting stents.
Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
Int J Cardiovasc Imaging; 2015 Feb; 31(2):269-77. PubMed ID: 25345751
[TBL] [Abstract][Full Text] [Related]
4. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
[TBL] [Abstract][Full Text] [Related]
5. Difference in statin effects on neointimal coverage after implantation of drug-eluting stents.
Yamamoto H; Ikuta S; Kobuke K; Yasuda M; Ikeda T; Yamaji K; Ueno M; Iwanaga Y; Miyazaki S
Coron Artery Dis; 2014 Jun; 25(4):290-5. PubMed ID: 24614628
[TBL] [Abstract][Full Text] [Related]
6. Comparison of zotarolimus-eluting stent and everolimus-eluting stent for vascular healing response: serial 3-month and 12-month optical coherence tomography study.
Kim SJ; Lee H; Cho JM; Park CB; Kim W; Kato K; Yonetsu T; Kim CJ; Jang IK
Coron Artery Dis; 2013 Aug; 24(5):431-9. PubMed ID: 23722649
[TBL] [Abstract][Full Text] [Related]
7. Serial randomized comparison of strut coverage of everolimus- and first-generation sirolimus-eluting stents.
Kim JS; Kim JH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Can J Cardiol; 2015 Jun; 31(6):723-30. PubMed ID: 25882337
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of stent strut coverage following angiography- or optical coherence tomography-guided percutaneous coronary intervention.
Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Rev Esp Cardiol (Engl Ed); 2015 Mar; 68(3):190-7. PubMed ID: 25487222
[TBL] [Abstract][Full Text] [Related]
9. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
[TBL] [Abstract][Full Text] [Related]
10. Early healing assessment with optical coherence tomography of everolimus-eluting stents with bioabsorbable polymer (synergy™) at 3 and 6 months after implantation.
de la Torre Hernández JM; Tejedor P; Camarero TG; Duran JM; Lee DH; Monedero J; Laso FS; Calderón MA; Veiga G; Zueco J
Catheter Cardiovasc Interv; 2016 Sep; 88(3):E67-73. PubMed ID: 26526783
[TBL] [Abstract][Full Text] [Related]
11. The relationship between post-stent strut apposition and follow-up strut coverage assessed by a contour plot optical coherence tomography analysis.
Kim JS; Ha J; Kim BK; Shin DH; Ko YG; Choi D; Jang Y; Hong MK
JACC Cardiovasc Interv; 2014 Jun; 7(6):641-51. PubMed ID: 24835329
[TBL] [Abstract][Full Text] [Related]
12. Three-month evaluation of strut healing using a novel optical coherence tomography analytical method following bioresorbable polymer everolimus-eluting stent implantation in humans: the TIMELESS study.
Vesga B; Hernandez H; Moncada M; Gasior P; Higuera S; Dager A; Arana C; Delgado JA; Généreux P; Maehara A; Granada JF
Coron Artery Dis; 2017 Mar; 28(2):126-134. PubMed ID: 27879518
[TBL] [Abstract][Full Text] [Related]
13. Randomised comparison of strut coverage between Nobori biolimus-eluting and sirolimus-eluting stents: an optical coherence tomography analysis.
Kim BK; Ha J; Mintz GS; Kim JS; Shin DH; Ko YG; Choi D; Jang Y; Hong MK
EuroIntervention; 2014; 9(12):1389-97. PubMed ID: 24531309
[TBL] [Abstract][Full Text] [Related]
14. Impact of statin treatment on strut coverage after drug-eluting stent implantation.
Suh Y; Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
Yonsei Med J; 2015 Jan; 56(1):45-52. PubMed ID: 25510746
[TBL] [Abstract][Full Text] [Related]
15. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
16. Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography.
Nakatani S; Nishino M; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
Catheter Cardiovasc Interv; 2013 Apr; 81(5):776-81. PubMed ID: 22517601
[TBL] [Abstract][Full Text] [Related]
17. One-year head to head comparison of the neointimal response between sirolimus eluting stent with reservoir technology and everolimus eluting stent: an optical coherence tomography study.
Shiratori Y; Brugaletta S; Alvarez-Contreras L; Azpeitia Y; Ospino N; Gaido S; Delahanty A; Santos A; Martin-Yuste V; Masotti M; Serruys PW; Windecker S; Sabaté M
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E428-36. PubMed ID: 23441068
[TBL] [Abstract][Full Text] [Related]
18. Serial Assessment of Strut Coverage of Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months After Stent Implantation by Optical Frequency Domain Imaging: The DISCOVERY 1TO3 Study (Evaluation With OFDI of Strut Coverage of Terumo New Drug Eluting Stent With Biodegradable Polymer at 1, 2, and 3 Months).
Chevalier B; Smits PC; Carrié D; Mehilli J; Van Boven AJ; Regar E; Sawaya FJ; Chamié D; Kraaijeveld AO; Hovasse T; Vlachojannis GJ
Circ Cardiovasc Interv; 2017 Dec; 10(12):. PubMed ID: 29246909
[TBL] [Abstract][Full Text] [Related]
19. Overtime evaluation of the vascular HEALing process after everolimus-eluting stent implantation by optical coherence tomography. The HEAL-EES study.
Otsuki S; Brugaletta S; Sabaté M; Shiratori Y; Gomez-Monterrosas O; Scalone G; Romero-Villafañe S; Hernández-Enríquez M; Freixa X; Martín-Yuste V; Masotti M
Cardiovasc Revasc Med; 2016 Jun; 17(4):241-7. PubMed ID: 27158001
[TBL] [Abstract][Full Text] [Related]
20. Optical coherence tomography analysis of the stent strut and prediction of resolved strut malapposition at 3 months after 2nd-generation drug-eluting stent implantation.
Izumi D; Miyahara M; Fujimoto N; Fukuoka S; Sakai M; Dohi K; Ito M
Heart Vessels; 2016 Aug; 31(8):1247-56. PubMed ID: 26334709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
